IVO 250 Pill - blue oval, 18mm
Generic Name: ivosidenib
Pill with imprint IVO 250 is Blue, Oval and has been identified as Tibsovo 250 mg. It is supplied by Agios Pharmaceuticals, Inc.
Tibsovo is used in the treatment of Biliary Tract Tumor; Acute Myeloid Leukemia; Myelodysplastic Syndrome and belongs to the drug class miscellaneous antineoplastics. Tibsovo 250 mg is not a controlled substance under the Controlled Substances Act (CSA).
Images for IVO 250
Tibsovo
- Generic Name
- ivosidenib
- Imprint
- IVO 250
- Strength
- 250 mg
- Color
- Blue
- Size
- 18.00 mm
- Shape
- Oval
- Availability
- Prescription only
- Drug Class
- Miscellaneous antineoplastics
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- Agios Pharmaceuticals, Inc.
- National Drug Code (NDC)
- 71334-0100
See also:
Keytruda
Keytruda is used to treat melanoma, non-small cell lung cancer, malignant pleural mesothelioma ...
Imfinzi
Imfinzi (durvalumab) is an immunotherapy used to treat types of lung cancer (NSCLC, SCLC), bile ...
Ozempic
Learn about Ozempic (semaglutide) for type 2 diabetes treatment, weight management, cardiovascular ...
Ziihera
Ziihera (zanidatamab) is a bispecific HER2-directed antibody used to treat HER2-positive biliary ...
Pemazyre
Pemazyre is used to treat certain types of bile duct cancer and myeloid/lymphoid neoplasms ...
Lytgobi
Lytgobi (futibatinib) is used for the treatment of bile duct cancer (intrahepatic ...
Pemigatinib
Pemigatinib is used for cholangiocarcinoma, myeloid/lymphoid neoplasms
More about Tibsovo (ivosidenib)
- Check interactions
- Compare alternatives
- Pricing & coupons
- Drug images
- Side effects
- Dosage information
- During pregnancy
- FDA approval history
- Drug class: miscellaneous antineoplastics
- Breastfeeding
- En español
Patient resources
Professional resources
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.